Alzheimer's disease(AD)is a neurodegenerative disease characterized by memory impairment and progressive cognitive decline. Currently AD is the most common cause to dementia, and its prevalence may rea ch up to 25% among elderly subjects older than 80 years of age. In addition to damaged high level cog nitive functions, electroencephalography-studies have showed impairment of early brain processing in AD. Magnetoencephalography(MEG), which offers excellent spatial and milliseconds temporal resolution, is ideal tool to study noninvasively cortical activity. We have shown with MEG that parallel auditory processing between the hemispheres underlying stimulus detection is selectively delayed in Parkinson's disease, AD and that delayed auditory processing correlates with cognitive decline in AD. Results of pharmacological studies with scopolamine, which temporarily blocks cholinergic receptors in the brain, indicate that auditory processing and spontaneous activity are modulated by the cholinergic system. Sensitivity to cholinergic modulation appears to be age-related in the auditory system. MEG results also indicate damaged auditory processing in Down syndrome(DS), which is characterized by mental retardation, and cholinergic damage similar to AD. Slowing of spontaneous brain activity is a common finding in AD progression. Present MEG-studies suggest altered oscillation activity in AD and in mild cognitive impairment(MCI), which often precedes dementia, compared with normal aging. Thus MEG might offer additional information to make a diagnosis between AD and MCI. Due to recent software development, MEG is now suitable to patients who have implanted deep brain stimulation(DBS)device. Our recent results tentatively suggest that DBS modulates somatosensory processing in PD. In conclusion, MEG appears to be a useful tool to study human brain activity in aging, neurodegenerative diseases, and even mental retardation.
View full abstract